Abstract

    Open Access Case Report Article ID: AHCRR-5-126

    Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration

    Temesgen Assefa* and Yosef Alebel

    Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm and myelodysplastic syndrome [1]. According to the 2016 WHO classification of hematologic malignancies it is categorized as MyeloDysplastic /Myeloproliferative Neoplasm [2].

    Keywords:

    Published on: Nov 7, 2020 Pages: 25-27

    Full Text PDF Full Text HTML DOI: 10.17352/ahcrr.000026
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Pinterest on AHCRR